Crohn's Disease and Ulcerative Colitis

1. The Genetics of Inflammatory Bowel Disease
Grace N. Gathungu, Judy H. Cho

2. Environmental Factors in the Epidemiology of Inflammatory Bowel Disease
Morten H. Vatn

3. The Intestinal Immune System in Health
Per Brandtzaeg

4. Understanding the Epithelial Barrier in Inflammatory Bowel Disease
Emily M. Bradford, Emily S. Turner, Jerrold R. Turner

5. Intestinal Microbiology and Ecology in Inflammatory Bowel Disease
Alan W. Walker

6. Microbial Recognition and Pathogen-Associated Molecular Pattern Receptors in Inflammatory Bowel Disease
Kenya Honda, Koji Atarashi, Junko Nishio

7. Inflammasomes in Inflammatory Bowel Disease
Till Strowig, Richard A. Flavell

8. Antimicrobial Peptides in Inflammatory Bowel Disease
Charles L. Bevins

9. Vascular Responses to Intestinal Inflammation in Inflammatory Bowel Disease
D. Neil Granger, Norman R. Harris

10. Immunobiology of Dendritic Cells in Inflammatory Bowel Disease
Daniel C. Baumgart

11. Immunobiology of T Cells in Inflammatory Bowel Disease
Scott B. Snapper, Deanna D. Nguyen

12. Immunobiology of B Cells in Inflammatory Bowel Disease
Atsushi Mizoguchi, Atul K. Bhan

13. Immunobiology of Monocytes and Macrophages in Inflammatory Bowel Disease
Kevin J. Woollard

14. Immunobiology of Epithelial Cells in Inflammatory Bowel Disease
Stephanie Dahan, Vera K. Denmark, Lloyd Mayer

15. The Th1, Th2, and Th17 Paradigm in Inflammatory Bowel Disease
Yasuhiro Nemoto, Mamoru Watanabe

16. Preclinical Studies Using Mouse Models of Inflammatory Bowel Disease
Fridrik Karlsson, Iurii Koboziev, Matthew B. Grisham

17. Enhanced Endoscopy in Inflammatory Bowel Disease
Ralf Kiesslich

18. MRI in Inflammatory Bowel Disease
Patrik Rogalla, Tanya Chawla

19. CT in Inflammatory Bowel Disease
Joel G. Fletcher

20. Ultrasound in Inflammatory Bowel Disease
C. Agné, M. Gebel

21. Laboratory Evaluation Including Novel Diagnostic Markers of Inflammatory Bowel Disease
Iris Dotan

22. Histology and Pathology of Inflammatory Bowel Disease
Nora E. Joseph, Christopher R. Weber

23. Activity Indices-Based Assessment of Disease Activity in Inflammatory Bowel Disease
Edouard Louis, Catherine Kemseke, Catherine Reenaers

24. Endoscopic Assessment of Disease Activity and Mucosal Healing in Inflammatory Bowel Disease
Haruhiko Ogata, Toshifumi Hibi

25. Evaluation of Quality of Life in Inflammatory Bowel Disease
Pia Munkholm, Natalia Pedersen

26. The Natural History of Inflammatory Bowel Disease
Charles N. Bernstein

27. Conventional Medical Management of Crohn’s Disease: Sulfasalazine
Miquel A. Gassull, Eduard Cabré

28. Conventional Medical Management of Crohn’s Disease: Corticosteroids
A. Hillary Steinhart

29. Conventional Medical Management of Crohn’s Disease: Azathioprine and 6-Mercaptopurine
Gil Kaplan, Lloyd R. Sutherland

30. Conventional Medical Management of Crohn’s Disease: Methotrexate
Eoin R. Storan, Laurence Egan

31. Biologic Treatment of Crohn’s Disease: Adalimumab
Remo Panaccione

32. Biologic Treatment of Crohn’s Disease: Certolizumab
Wojciech Blonski, Gary R. Lichtenstein

33. Biologic Therapy of Crohn’s Disease: Infliximab
Frank Hoentjen, Atsushi Sakuraba, Stephen Hanauer

34. Biologic Treatment of Crohn’s Disease: Briakinumab and Ustekinumab
Peter Mannon

35. Biologic Therapy of Crohn’s Disease: Natalizumab, Vedolizumab, CCX282-B
Alvin Chung, Peter R. Gibson

36. Conventional Medical Management of Ulcerative Colitis: Sulfasalazine and 5-Aminosalicylates
Reena Khanna, John K. Marshall

37. Conventional Medical Management of Ulcerative Colitis: Corticosteroids
A. Hillary Steinhart

38. Conventional Medical Management of Ulcerative Colitis: Azathioprine
Barrett G. Levesque, Edward V. Loftus

39. Conventional Medical Management of Ulcerative Colitis: Cyclosporine
Gert Assche

40. Conventional Medical Management of Ulcerative Colitis: Tacrolimus
Daniel C. Baumgart

41. Biologic Therapy of Ulcerative Colitis: Infliximab, Adlimumab, Golimumab
Walter Reinisch

42. Biologic Therapy of Ulcerative Colitis: Natalizumab, Vedolizumab, Etrolizumab (rhuMAb β7)
Julián Panés, Daniel Benítez-Ribas, Azucena Salas

43. Probiotics, Prebiotics, and Antibiotics in Medical Management of Inflammatory Bowel Disease
Paolo Gionchetti, Fernando Rizzello

44. Step-Up vs. Top-Down Approach in Medical Management of Inflammatory Bowel Disease
Anne Christine W. Vos, Daniel W. Hommes

45. Surgical Management of Crohn’s Disease and Ulcerative Colitis
Robert R. Cima, John H. Pemberton

46. Extraintestinal Manifestations of Inflammatory Bowel Disease: Autoimmune Hepatitis
Nora Schweitzer, Michael P. Manns

47. Extraintestinal Manifestations of Inflammatory Bowel Disease: Primary Sclerosing Cholangitis
John Halliday, Roger W. Chapman

48. Extraintestinal Manifestations of Inflammatory Bowel Disease: Autoimmune Pancreatitis and Other IgG4-Related Conditions
Terumi Kamisawa, Taku Tabata, Go Kuwata, Koichi Koizumi

49. Extraintestinal Manifestations of Inflammatory Bowel Disease: Cutaneous and Oral Manifestations of Inflammatory Bowel Disease
Caroline P. Allen, Susan M. Burge

50. Extraintestinal Manifestations of Inflammatory Bowel Disease: Arthritis, Arthropathy and Osteoporosis
Roger Sturrock, Jagtar Singh Nijjar

51. Nutrition in Inflammatory Bowel Disease
Alan L. Buchman

52. Fertility and Pregnancy in Inflammatory Bowel Disease
Sharmeel K. Wasan, Sunanda Kane

53. Pediatric Aspects in Inflammatory Bowel Disease
Jeffrey S. Hyams

54. Management and Prevention of Infectious Diseases in Inflammatory Bowel Disease Patients
Kristine Macartney, Nigel Crawford

55. Diagnosis and Management of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease
Aarti Kakkar, Francis A. Farraye

56. How to Identify High-Risk Patients in Inflammatory Bowel Disease?
Jacques Cosnes, Harry Sokol, Philippe Seksik

57. Patient Perspective on Inflammatory Bowel Disease
Marjorie Merrick

58. Patient Resources in Inflammatory Bowel Disease
Ben Wilson, Marco Greco

Avainsanat: Medicine & Public Health, Gastroenterology